Rapid Test Kit Market Is Expected To Reach USD 26.55 Billion in 2030 at a Healthy CAGR of 7.3% – Reports and Data

September 23 19:52 2022
Rapid Test Kit Market Is Expected To Reach USD 26.55 Billion in 2030 at a Healthy CAGR of 7.3% - Reports and Data
Rapid Test Kit Market
The global rapid test kit market size is expected to reach USD 26.55 Billion in 2030 and register a revenue CAGR of 7.3% over the forecast period, according to the latest report by Reports and Data.

The global rapid test kit market size is expected to reach USD 26.55 Billion in 2030 and register a revenue CAGR of 7.3% over the forecast period, according to latest report by Reports and Data. Increasing prevalence of various infectious diseases is driving rapid testing kit market revenue growth. Use of rapid test kits in the food industry to detect foodborne pathogens and ensure faster and effective real-time food testing is also expected to boost market revenue.

Governments across the world are taking initiatives to boost mandatory testing. In January 2022, the US Government announced the purchase of one billion rapid test kits, which aims to promote testing capacity and mitigate the spread of COVID-19 throughout the country. Steady increase in the number of testing centers approved by the government and increase in the number of private points of care centers is driving the rapid test kit market revenue growth.

Moreover, the use of advanced technologies in these kits are immunoassay or chromatography based, which delivers prompt results. The demand for such rapid test kits has grown significantly. Governments of most countries have implemented stringent pathogen testing to reduce the spread of COVID-19. Medical firms, mostly diagnostic service providers, are establishing positions in the rapid test kit industry, which is expected to drive global market revenue growth during the forecast period.

However, failing to eradicate the need for microscopy for more accurate results and lack of awareness of the newer and advanced rapid test kits among the population are factors challenging growth of rapid test kits market revenue growth. Moreover, many rapid antigen test kits include chemical preservatives such as ProClin and liquids such as Sodium Azide. These fluids are associated with potential risks due to misuse or accidental spillage on the skin or eye and ingestion, resulting in allergic reactions, skin and eye irritation, and serious health hazards. Accidental spillage or misuse of these fluids may not have very serious effects on adults but can prove to be hazardous in the case of children and pets.

Some Key Highlights in the Report:

  • RT-PCR segment accounted for a significantly large revenue share in global rapid test kit market in 2021 due to the sudden outbreak of COVID-19 and mandatory testing orders.
  • Pregnancy and fertility segment revenue is expected to register a faster CAGR during the forecast period owing to the high accuracy of the result and low complexity in the use of these kits.
  • Rapid test kit market in Asia Pacific is expected to register a steady revenue growth rate over the forecast period owing to rising patient pool of various infectious and chronic diseases. In order to increase the availability of the kits, majority of the medical manufacturers are expanding their manufacturing units in this region owing to low-cost labor available there. This is expected to boost market revenue growth in the region.
  • Rapid test kit market in Europe is expected to register a significantly rapid revenue growth rate during the forecast period. Market revenue growth is expected to be driven by stringent regulations of the governments on mass testing to curb the spread of COVID-19. Thus, increase in demand for these kits is expected to drive market revenue growth in the region.
  • On September 28, 2020, the WHO announced global partnerships with the Bill & Melinda Gates Foundation, the Clinton Health Access Initiative (CHAI), the Africa Centers of Disease, Control and Prevention (Africa CDC), the Foundation for Innovative New Diagnostics, and the Global Fund Unitaid to make available 120 million quality rapid test kits of COVID-19 to Low and Middle-Income Countries (LMICs).


Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2964


Increased adoption of convenient home testing kits with fast and accurate results is driving rapid test kits market revenue growth – Our Expert Opinion


Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.

The growing popularity of over-the-counter medications driving market growth

Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.

Restriction on product launches and R&D activities to hamper the market growth

The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.


Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.

Top Companies Profiled in the Report:

Abbott, Thermo Fisher Scientific, Ray Biotech Life, Inc., OraSure Technologies, BioMedomics Inc., CTK Biotech, Inc., AlphaBiolabs Ltd., GeneMatrix Inc., Seegene Inc., and Beijing Tigsun Diagnostics Co. Ltd.

Rapid Test Kit Market Segmentation:

Test type Outlook (Revenue, USD Billion; 2019–2030)

  • Rapid Antigen Test
  • Rapid Antibody Test


Kit type Outlook (Revenue, USD Billion; 2019–2030)

  • Over-The-Counter rapid test kits
  • Professional Rapid Test Kits
  • Others


Technology Outlook (Revenue, USD Billion; 2019–2030)

  • Lateral Flow Immunoassay
  • Solid Phase
  • Agglutination
  • Chromatography
  • Spectroscopy


Application Outlook (Revenue, USD Billion; 2019–2030)

  • Infectious Diseases
  • Glucose Monitoring
  • Pregnancy and Fertility
  • Food Safety Testing
  • Drug Abuse Testing
  • Others


Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)


Frequently asked questions addressed in the report:

  • What is the revenue growth rate of the global Rapid Test Kit market over the forecast period?
  • What are the major factors driving the growth of the Global Rapid Test Kit Market?
  • What are the key challenges impacting the global Rapid Test Kit market growth?
  • What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?


Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.

Explore Latest Trending Research Reports By Reports and Data:

Global Medical Transcription Market @ https://www.reportsanddata.com/report-detail/medical-transcription-market 

Examination Nitrile Gloves Market @ https://www.reportsanddata.com/report-detail/examination-nitrile-gloves-market 

Nanoparticle Drug Delivery Systems Market @ https://www.reportsanddata.com/report-detail/nanoparticle-drug-delivery-systems-market  

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/rapid-test-kit-market